989 related articles for article (PubMed ID: 14516206)
21. Metal complexes as DNA intercalators.
Liu HK; Sadler PJ
Acc Chem Res; 2011 May; 44(5):349-59. PubMed ID: 21446672
[TBL] [Abstract][Full Text] [Related]
22. Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands.
Habtemariam A; Melchart M; Fernandez R; Parsons S; Oswald ID; Parkin A; Fabbiani FP; Davidson JE; Dawson A; Aird RE; Jodrell DI; Sadler PJ
J Med Chem; 2006 Nov; 49(23):6858-68. PubMed ID: 17154516
[TBL] [Abstract][Full Text] [Related]
23. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ
Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447
[TBL] [Abstract][Full Text] [Related]
24. Cellular delivery of pyrenyl-arene ruthenium complexes by a water-soluble arene ruthenium metalla-cage.
Furrer MA; Schmitt F; Wiederkehr M; Juillerat-Jeanneret L; Therrien B
Dalton Trans; 2012 Jun; 41(24):7201-11. PubMed ID: 22506276
[TBL] [Abstract][Full Text] [Related]
25. The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.
Bugarcic T; Habtemariam A; Stepankova J; Heringova P; Kasparkova J; Deeth RJ; Johnstone RD; Prescimone A; Parkin A; Parsons S; Brabec V; Sadler PJ
Inorg Chem; 2008 Dec; 47(24):11470-86. PubMed ID: 19007206
[TBL] [Abstract][Full Text] [Related]
26. DNA interactions of dinuclear RuII arene antitumor complexes in cell-free media.
Nováková O; Nazarov AA; Hartinger CG; Keppler BK; Brabec V
Biochem Pharmacol; 2009 Feb; 77(3):364-74. PubMed ID: 19014908
[TBL] [Abstract][Full Text] [Related]
27. Binding of mismatch repair protein MutS to mispaired DNA adducts of intercalating ruthenium(II) arene complexes.
Castellano-Castillo M; Kostrhunova H; Marini V; Kasparkova J; Sadler PJ; Malinge JM; Brabec V
J Biol Inorg Chem; 2008 Aug; 13(6):993-9. PubMed ID: 18491151
[TBL] [Abstract][Full Text] [Related]
28. DNA interactions of a novel platinum drug, cis-[PtCl(NH3)2(N7-acyclovir)]+.
Balcarová Z; Kaspárková J; Zákovská A; Nováková O; Sivo MF; Natile G; Brabec V
Mol Pharmacol; 1998 May; 53(5):846-55. PubMed ID: 9584210
[TBL] [Abstract][Full Text] [Related]
29. Competition between glutathione and DNA oligonucleotides for ruthenium(II) arene anticancer complexes.
Wang F; Xu J; Wu K; Weidt SK; Mackay CL; Langridge-Smith PR; Sadler PJ
Dalton Trans; 2013 Mar; 42(9):3188-95. PubMed ID: 23076358
[TBL] [Abstract][Full Text] [Related]
30. Chloro half-sandwich osmium(II) complexes: influence of chelated N,N-ligands on hydrolysis, guanine binding, and cytotoxicity.
Peacock AF; Habtemariam A; Moggach SA; Prescimone A; Parsons S; Sadler PJ
Inorg Chem; 2007 May; 46(10):4049-59. PubMed ID: 17441712
[TBL] [Abstract][Full Text] [Related]
31. Phenanthroline ligands are biologically more active than their corresponding ruthenium(II) arene complexes.
Valladolid J; Hortigüela C; Busto N; Espino G; Rodríguez AM; Leal JM; Jalón FA; Manzano BR; Carbayo A; García B
Dalton Trans; 2014 Feb; 43(6):2629-45. PubMed ID: 24327227
[TBL] [Abstract][Full Text] [Related]
32. Ruthenium (II) nitrofurylsemicarbazone complexes: new DNA binding agents.
Cabrera E; Cerecetto H; González M; Gambino D; Noblia P; Otero L; Parajón-Costa B; Anzellotti A; Sánchez-Delgado R; Azqueta A; López de Ceráin A; Monge A
Eur J Med Chem; 2004 Apr; 39(4):377-82. PubMed ID: 15072846
[TBL] [Abstract][Full Text] [Related]
33. Dual triggering of DNA binding and fluorescence via photoactivation of a dinuclear ruthenium(II) arene complex.
Magennis SW; Habtemariam A; Novakova O; Henry JB; Meier S; Parsons S; Oswald ID; Brabec V; Sadler PJ
Inorg Chem; 2007 Jun; 46(12):5059-68. PubMed ID: 17497848
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes.
Scolaro C; Bergamo A; Brescacin L; Delfino R; Cocchietto M; Laurenczy G; Geldbach TJ; Sava G; Dyson PJ
J Med Chem; 2005 Jun; 48(12):4161-71. PubMed ID: 15943488
[TBL] [Abstract][Full Text] [Related]
35. Modification of natural, double-helical DNA by antitumor cis- and trans-[Cl(2)(Me(2)SO(4))(4)Ru] in cell-free media.
Nováková O; Hofr C; Brabec V
Biochem Pharmacol; 2000 Dec; 60(12):1761-71. PubMed ID: 11108791
[TBL] [Abstract][Full Text] [Related]
36. Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity.
Peacock AF; Parsons S; Sadler PJ
J Am Chem Soc; 2007 Mar; 129(11):3348-57. PubMed ID: 17319668
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, characterization and DNA binding studies of new ruthenium(II)bisterpyridine complexes.
Sathyaraj G; Weyhermüller T; Nair BU
Eur J Med Chem; 2010 Jan; 45(1):284-91. PubMed ID: 19879670
[TBL] [Abstract][Full Text] [Related]
38. Unique properties of DNA interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand.
Kasparkova J; Vojtiskova M; Natile G; Brabec V
Chemistry; 2008; 14(4):1330-41. PubMed ID: 18022972
[TBL] [Abstract][Full Text] [Related]
39. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
[TBL] [Abstract][Full Text] [Related]
40. Transferrin serves as a mediator to deliver organometallic ruthenium(II) anticancer complexes into cells.
Guo W; Zheng W; Luo Q; Li X; Zhao Y; Xiong S; Wang F
Inorg Chem; 2013 May; 52(9):5328-38. PubMed ID: 23586415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
